For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of Vyndamax read more and the formulated version represents a significant breakthrough . These novel therapies protect the transthyretin protein, slowing its destructive build-up and reducing the burden of the condition . People are now